New cancer clinical trial: Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

Published on: October 30, 2018 at 12:00PM
Condition:   Neuroendocrine Tumors
Intervention:   Drug: [90]Y-DOTATOC
Sponsors:   Sandeep Laroia;   National Institutes of Health (NIH);   Holden Comprehensive Cancer Center;   National Cancer Institute (NCI)
Recruiting
https://ift.tt/2qimPm9